49 results
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
on which the Executive provides the Company with the Notice of Termination.
(iii)
“Disability” means the inability of the Executive to substantially … as of the Date of Termination; or
(vii)
by the Company as a result of Disability, but nothing in this section 4(b)(vii) will reduce the Executive’s rights
8-K
EX-10.1
9yjgtto cy
19 Jul 22
InMed Announces Appointment of Chief Operating Officer
7:43pm
424B5
jcvtxaz2
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
de4ifmqf8tt
25 Apr 22
Prospectus supplement
5:02pm
424B3
amt50vqo5z5nfl
7 Apr 22
Prospectus supplement
4:46pm
S-3
j9xxt4 pvaqr
4 Feb 22
Shelf registration
4:36pm
DEF 14A
710efts8b7yf3j5 7f
28 Oct 21
Definitive proxy
3:07pm
8-K
EX-2.1
py3 b4avnlbblp8d6i
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
0f0rs3u16e xh
24 Sep 21
Annual report
7:31am
10-K
EX-2.1
91n8p rpe
24 Sep 21
Annual report
7:31am
424B3
iexzsw4
22 Jul 21
Prospectus supplement
10:27am